Stem cell (SVF) breast augmentation

Stem cells in adipose tissue (SVF) activate angiogenesis and cell regeneration, resulting in a higher engraftment rate than simple fat grafting. The average engraftment rate of SC301, 77.48%, is a figure officially listed in SCI journals.

While implants carry the risk of future replacement or side effects due to the insertion of foreign materials, SVF differs fundamentally in that it involves the transplantation of autologous tissue, minimizing the burden of foreign body reactions, and once engrafted, the fat cells become part of the patient's own breast tissue to be maintained. Furthermore, it offers a natural feel and movement, and as a procedure distinct from the rippling or capsular contracture characteristic of implants, one can expect a healthy sense of volume.

Even lean body types with low fat content can secure sufficient graft volume through personalized pre-procedure management. Cases have also been reported in ballerina and model body types, and you can verify your estimated range during the consultation using a 3D volume measurement device.

Stem cell (SVF) breast augmentation is performed through a single 2mm micro-hole, resulting in minimal pain and rapid recovery. Generally, patients can be discharged on the same day of surgery and immediately resume light daily activities. In particular, our clinic systematically monitors the engraftment process through a professional pre- and post-operative care program, helping you quickly achieve a natural silhouette without the need for artificial shapewear.

Yes. Volume loss after childbirth and breastfeeding is a common concern discussed during consultations for stem cell (SVF) fat grafting. However, since the most suitable method varies depending on the degree of sagging, the amount of fat available for harvesting, and skin elasticity, it is determined through a medical examination.

SC301 Clinic measures the actual number of SVF cells injected for each surgery using a cell counter. In publicly disclosed cases of breast stem cell (SVF) fat grafting, the number of cells injected per session ranged from approximately 68 million to 99 million, depending on the amount and condition of the harvested fat.

Bruising, swelling, and pain may occur at the harvest and transplant sites, and rarely, infection, fat necrosis, sebaceous cysts, calcification, asymmetry, or depression at the harvest site may occur. The degree of engraftment varies from person to person. Individual risk factors are identified during the pre-operative consultation.